• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON LABORATORIES IRELAND LTD. CLAREON PANOPTIX TRIFOCAL HYDROPHOBIC INTRAOCULAR LENS; LENS, MULTIFOCAL INTRAOCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON LABORATORIES IRELAND LTD. CLAREON PANOPTIX TRIFOCAL HYDROPHOBIC INTRAOCULAR LENS; LENS, MULTIFOCAL INTRAOCULAR Back to Search Results
Model Number CNWTT0
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Retinal Degeneration (2049); Visual Disturbances (2140); Posterior Capsule Opacification (4807)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
A healthcare professional reported that following an intraocular lens (iol) implant procedure, the patient experienced glare sensitive, shadowing, jumping/flickering at near (even with refractive prescription (srx) on +0.50 -0.50 x 165).Surgeon noted flickering/fluttering happens when eyes move quickly from one place to another.Surgeon also noted some mild lattice degeneration inferiorly (no tears or tobacco dust), minimal posterior capsule opacification (pco).The iol was still in patient eye.Additional information has been requested.
 
Additional Manufacturer Narrative
Additional information was provided in h.3., h.6.And h.11.The product was not returned for analysis.The root cause for the reported complaint could not be determined.The instructs for use (ifu) states that some visual effects may be expected due to the superposition of focused and unfocused multiple images.These may include some perception of halos, radial lines around point sources of light (starbursts) under night-time conditions, or glare, as well as other visual symptoms.As with other multifocal intraocular lens (iols), there is a possibility that visual symptoms may be significant enough that the patient will request explant of the multifocal iol.Based on the results from the product history record, the products met release criteria.The manufacturer internal reference number is: (b)(4).
 
Additional Manufacturer Narrative
The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
Additional information has been requested and received that the patient has visited the clinic again with excellent vision.Additionally, it was mentioned that the patient still getting the flickering temporally though no abnormality detected on magnetic resonance imaging (mri).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLAREON PANOPTIX TRIFOCAL HYDROPHOBIC INTRAOCULAR LENS
Common Device Name
LENS, MULTIFOCAL INTRAOCULAR
Manufacturer (Section D)
ALCON LABORATORIES IRELAND LTD.
cork business&technology park
model farm road
cork 00000
EI  00000
Manufacturer (Section G)
ALCON LABORATORIES IRELAND LTD.
cork business&technology park
model farm road
cork 00000
EI   00000
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key20632737
Report Number9612169-2024-01130
Device Sequence Number7393462
Product Code MFK
UDI-Device Identifier00380652408141
UDI-Public(01)00380652408141(17)260529(11)220531(10)25424122
Combination Product (Y/N)N
Initial Reporter CountryAS
PMA/510(K) Number
P190018
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 04/04/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date05/29/2026
Device Model NumberCNWTT0
Device Catalogue NumberCNWTT0.210
Device Lot Number25424122
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 10/09/2024
Supplement Date Received by Manufacturer12/12/2024
03/06/2025
Initial Report FDA Received Date11/07/2024
Supplement Report FDA Received Date01/03/2025
04/05/2025
Date Device Manufactured05/31/2022
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
CLAREON MONARCH IV IOL DELIVERY SYSTEM, INJECTOR.; CLAREON MONARCH IV IOL, INJECTOR.; MONARCH III IOL DELIVERY SYSTEM, CARTRIDGE D.; MONARCH III IOL, CARTRIDGE D.; PROVISC OPHTHALMIC VISCOSURGICAL DEVICE.
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-